A Predictive Genetic Signature for Response to Fluoropyrimidine-Based Neoadjuvant Chemoradiation in Clinical Stage II and III Rectal Cancer

A Predictive Genetic Signature for Response to Fluoropyrimidine-Based Neoadjuvant Chemoradiation in Clinical Stage II and III Rectal Cancer

Pre-operative chemoradiation (CRT) is currently the standard of care for patients with clinical stage II and III rectal cancer but only about 45% of patients achieve tumor downstaging and

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in oncology 2013-01, Vol.3, p.288-288
Hauptverfasser: Chan, Jason, Kinsella, Michael T, Willis, Joseph E, Hu, Huankai, Reynolds, Jr, Harry, Delaney, Conor, McCulla, Andrea, Deharo, Steve, Ahdesmäki, Miika, Allen, Wendy Louise, Johnston, Patrick G, Kinsella, Timothy J
Format: Artikel
Sprache:eng
Schlagworte:
EHBP1
Gene array
Oncology
Rectal Neoplasms
UBC
ubiquination
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Pre-operative chemoradiation (CRT) is currently the standard of care for patients with clinical stage II and III rectal cancer but only about 45% of patients achieve tumor downstaging and
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2013.00288